132 related articles for article (PubMed ID: 32533161)
1. Is tumour location a prognostic factor for pharmacological treatment in patients with desmoid-type fibromatosis? a systematic review.
Koike H; Hamada S; Sakai T; Shimizu K; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Sep; 50(9):1032-1036. PubMed ID: 32533161
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
Shimizu K; Kawashima H; Kawai A; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Oct; 50(11):1274-1281. PubMed ID: 32700733
[TBL] [Abstract][Full Text] [Related]
4. Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
Sakai T; Hamada S; Koike H; Shimizu K; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Sep; 50(9):1037-1042. PubMed ID: 32533146
[TBL] [Abstract][Full Text] [Related]
5. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
Toulmonde M; Pulido M; Ray-Coquard I; Andre T; Isambert N; Chevreau C; Penel N; Bompas E; Saada E; Bertucci F; Lebbe C; Le Cesne A; Soulie P; Piperno-Neumann S; Sweet S; Cecchi F; Hembrough T; Bellera C; Kind M; Crombe A; Lucchesi C; Le Loarer F; Blay JY; Italiano A
Lancet Oncol; 2019 Sep; 20(9):1263-1272. PubMed ID: 31331699
[TBL] [Abstract][Full Text] [Related]
6. Desmoid-type fibromatosis: toward a holistic management.
Penel N; Kasper B; van Der Graaf WTA
Curr Opin Oncol; 2021 Jul; 33(4):309-314. PubMed ID: 33973549
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of cyclooxygenase 2 inhibitors for desmoid tumor management: a systematic review.
Emori M; Matsumoto Y; Murahashi Y; Yoshida M; Nishida Y
Nagoya J Med Sci; 2021 Nov; 83(4):673-681. PubMed ID: 34916712
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of surgical treatment for asymptomatic patients with extra-peritoneal desmoid-type fibromatosis: a systematic review and meta-analysis.
Kito M; Ogose A; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 May; 50(5):574-580. PubMed ID: 32115631
[TBL] [Abstract][Full Text] [Related]
9. Comparison of sporadic and FAP-associated desmoid-type fibromatoses.
Koskenvuo L; Ristimäki A; Lepistö A
J Surg Oncol; 2017 Nov; 116(6):716-721. PubMed ID: 28570749
[TBL] [Abstract][Full Text] [Related]
10. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.
Palassini E; Frezza AM; Mariani L; Lalli L; Colombo C; Fiore M; Messina A; Casale A; Morosi C; Collini P; Stacchiotti S; Casali PG; Gronchi A
Cancer J; 2017; 23(2):86-91. PubMed ID: 28410293
[TBL] [Abstract][Full Text] [Related]
11. Desmoid-type fibromatoses involving the brachial plexus: treatment options and assessment of c-KIT mutational status.
Seinfeld J; Kleinschmidt-Demasters BK; Tayal S; Lillehei KO
J Neurosurg; 2006 May; 104(5):749-56. PubMed ID: 16703880
[TBL] [Abstract][Full Text] [Related]
12. Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis.
Fiore M; Colombo C; Radaelli S; Callegaro D; Palassini E; Barisella M; Morosi C; Baldi GG; Stacchiotti S; Casali PG; Gronchi A
Eur J Cancer; 2015 Dec; 51(18):2800-7. PubMed ID: 26602014
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy in fibromatoses of childhood and adolescence: results from the Cooperative soft tissue sarcoma study (CWS) and the Italian Cooperative study group (ICG-AIEOP)].
Pilz T; Pilgrim TB; Bisogno G; Knietig R; Koscielniak E; Carli M; Treuner J
Klin Padiatr; 1999; 211(4):291-5. PubMed ID: 10472564
[TBL] [Abstract][Full Text] [Related]
14. An unusual finding in a desmoid-type fibromatosis of the pancreas: a case report and review of the literature.
Torres JC; Xin C
J Med Case Rep; 2018 May; 12(1):123. PubMed ID: 29751773
[TBL] [Abstract][Full Text] [Related]
15. [Low-dose methotrexate combined with vinorelbine for inoperable desmoid tumor: efficacy and the prognostic factors].
Fan Z; Li S; Fang Z; Liu J; Bai C; Xue R; Zhang L; Gao T
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):39-43. PubMed ID: 26806736
[TBL] [Abstract][Full Text] [Related]
16. MRI characteristics predict the efficacy of meloxicam treatment in patients with desmoid-type fibromatosis.
Shimizu K; Hamada S; Sakai T; Ito S; Urakawa H; Arai E; Ikuta K; Koike H; Ishiguro N; Nishida Y
J Med Imaging Radiat Oncol; 2019 Dec; 63(6):751-757. PubMed ID: 31448875
[TBL] [Abstract][Full Text] [Related]
17. Medical treatment of mammary desmoid-type fibromatosis: which benefit?
Scheer L; Lodi M; Molière S; Kurtz JE; Mathelin C
World J Surg Oncol; 2017 Apr; 15(1):86. PubMed ID: 28420393
[TBL] [Abstract][Full Text] [Related]
18. Morphologic and immunophenotypic analysis of desmoid-type fibromatosis after radiation therapy.
Cates JM; Black J; Wolfe CC; Shinohara ET; Holt GE; Keedy VL; Hande KR; Homlar KC; Halpern JL; Schwartz HS; Troutman A; Coffin CM
Hum Pathol; 2012 Sep; 43(9):1418-24. PubMed ID: 22404950
[TBL] [Abstract][Full Text] [Related]
19. [Facial infantile aggressive fibromatosis: a frequent localization of an exceptional tumor!].
Bouguila J; Khonsari RH; Zitouni K; Zairi I; Adouani A
Ann Chir Plast Esthet; 2012 Jun; 57(3):304-7. PubMed ID: 20561731
[TBL] [Abstract][Full Text] [Related]
20. Desmoid tumors: who, when and how to treat?
Mikhael R; Smith M; Tzanis D; Watson S; Miah AB; Bonvalot S
Curr Opin Oncol; 2022 Jul; 34(4):335-341. PubMed ID: 35837705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]